Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhaskar Srivastava

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Pharmacy & Bioallied Sciences|June 13, 2025
A Cephalometric Study of Cervical Vertebrae Maturation to Evaluate Mandibular Growth at Different Levels in Skeletal Class I and Class II MalocclusionsOishi Chatterjee, Kanchan Sharma, Rajalaxmi Sahu, et al.
Journal of the American Academy of Dermatology|December 2, 2014
The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neckOmer Ibrahim, Christopher G Bunick, Bhaskar Srivastava, et al.
Journal of the American Academy of Dermatology|August 18, 2020
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysisRichard G Langley, Yves Poulin, Bhaskar Srivastava, et al.
Cancer Research|April 17, 2014
Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγPing-Chih Ho, Katrina M Meeth, Yao-Chen Tsui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Development and selection of edited B cells in B6.56R miceDebora R Sekiguchi, Lenka Yunk, David Gary, et al.
BMC Rheumatology|December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologicsChristopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
Journal of the American Academy of Dermatology|September 13, 2017
Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment RegistryDavid Fiorentino, Vincent Ho, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe PsoriasisSteven R Feldman, Bhaskar Srivastava, Jill Abell, et al.
American Journal of Clinical Dermatology|September 30, 2018
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Sanminder Singh, Robert E Kalb, Elke M G J de Jong, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2019
Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Rosemary deShazo, Razieh Soltani-Arabshahi, Shalini Krishnasamy, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Pharmacy & Bioallied Sciences|June 13, 2025
A Cephalometric Study of Cervical Vertebrae Maturation to Evaluate Mandibular Growth at Different Levels in Skeletal Class I and Class II MalocclusionsOishi Chatterjee, Kanchan Sharma, Rajalaxmi Sahu, et al.
Journal of the American Academy of Dermatology|December 2, 2014
The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neckOmer Ibrahim, Christopher G Bunick, Bhaskar Srivastava, et al.
Journal of the American Academy of Dermatology|August 18, 2020
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysisRichard G Langley, Yves Poulin, Bhaskar Srivastava, et al.
Cancer Research|April 17, 2014
Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγPing-Chih Ho, Katrina M Meeth, Yao-Chen Tsui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Development and selection of edited B cells in B6.56R miceDebora R Sekiguchi, Lenka Yunk, David Gary, et al.
BMC Rheumatology|December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologicsChristopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
Journal of the American Academy of Dermatology|September 13, 2017
Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment RegistryDavid Fiorentino, Vincent Ho, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe PsoriasisSteven R Feldman, Bhaskar Srivastava, Jill Abell, et al.
American Journal of Clinical Dermatology|September 30, 2018
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Sanminder Singh, Robert E Kalb, Elke M G J de Jong, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2019
Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Rosemary deShazo, Razieh Soltani-Arabshahi, Shalini Krishnasamy, et al.
Pageof 3